<DOC>
	<DOCNO>NCT02252328</DOCNO>
	<brief_summary>The trial compare effect disease control immunosuppression treatment add simvastatin 80mg daily , follow-up treatment period 2 year . Patients randomise 1:1 fashion standard treatment placebo standard treatment addition simvastatin ( 80mg daily ) . They follow 3 month interval 2 year primary end point mean reduction corticosteroid dosage 12 month follow-up visit .</brief_summary>
	<brief_title>Use Simvastatin Steroid Sparing Agent Uveitis Patients</brief_title>
	<detailed_description>This non-commercial trial explore effect simvastatin 80mg od dose corticosteroid immunosuppression patient sight-threatening uveitis . In order detect clinical effect study design double blind , parallel group , placebo-controlled , randomised trial . Double blind achieve use placebo well mask clinical assessor . Based report effect simvastatin brain atrophy among multi [ le sclerosis patient 12 month treatment , patient receive treatment placebo treat follow 24 month . Patients randomise simvastatin receive dose 80mg od . There dose escalation . Patients review every 3 month undergo complete ophthalmic examination treatment adjustment accordingly .</detailed_description>
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Patients must &gt; 18 year 80 year . 2 . Both sex may participate , , possible teratogenicity simvastatin woman may follow counsel need adequate contraception . 3 . Women child bear potential negative pregnancy test prior enrolment . 4 . Patients must previously diagnose intermediate , posterior panuveitis ( define standardization uveitis nomenclature group ) .14 5 . Patients must take systemic prednisolone 10mg daily . 6 . Patients may treat without second line agent . 7 . Patients must willing able provide inform consent 1 . No associated underlying systemic disease cause uveitis . 2 . Females childbearing potential male must willing use effective method contraception ( hormonal barrier method birth control ; abstinence ) time consent sign 6 week treatment discontinuation . 3 . Females childbearing potential must negative pregnancy test within 7 day prior registered trial treatment . 4 . Females must breastfeed . 5 . Patients concomitantly take ciclosporin , fibrates , amiodarone , amlodipine , verapamil , cytochrome P450 3A4 inhibitor ( e.g . itraconazole , ketoconazole , posaconazole , voriconazole ) , HIV protease inhibitor ( e.g . nelfinavir ) , erythromycin , clarithromycin , telithromycin , nefazodone , gemfibrozil , danazol , fusidic acid , diltiazem anticoagulant . 6 . Patients advise drink grapefruit juice study . 7 . Family history hereditary muscle disorder . 8 . Active Liver disease 9 . Severe renal insufficiency . 10 . Persistently elevate serum transaminase . 11 . Allergies excipients simvastatin placebo 12 . Lactose intolerance 13 . Involvement clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Uveitis</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>Visual acuity</keyword>
	<keyword>Corticosteroids</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>